Milestone Pharmaceuticals Inc. Common Shares MIST
$1.05
+2.43%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | FORM 8-K | 2026-08-12 | View → |
| 10-Q | 10-Q | 2026-08-12 | View → |
| 8-K | FORM 8-K | 2026-06-15 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| S-3 | S-3 | 2026-05-13 | View → |
| 8-K | FORM 8-K | 2026-05-13 | View → |
| 10-Q | 10-Q | 2026-05-13 | View → |
| DEF 14A | FORM DEF 14A | 2026-04-30 | View → |
| 4 | Insider transaction | 2026-04-20 | View → |
| 8-K | FORM 8-K | 2026-03-20 | View → |
| 10-K | 10-K | 2026-03-20 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-01-28 | View → |
| 4 | Insider transaction | 2026-01-28 | View → |
| 4 | Insider transaction | 2026-01-28 | View → |
| 4 | Insider transaction | 2026-01-28 | View → |
| 4 | Insider transaction | 2026-01-28 | View → |
| 8-K | FORM 8-K | 2026-01-26 | View → |
| 8-K | FORM 8-K | 2026-01-13 | View → |
| 4 | Insider transaction | 2026-01-09 | View → |
| 8-K | FORM 8-K | 2026-01-06 | View → |
| 8-K | FORM 8-K | 2025-12-15 | View → |
| 4 | Insider transaction | 2025-12-11 | View → |
| 8-K | FORM 8-K | 2025-11-12 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | FORM 8-K | 2025-08-12 | View → |
| 10-Q | 10-Q | 2025-08-12 | View → |
| 4 | Insider transaction | 2025-07-15 | View → |
| 4 | Insider transaction | 2025-07-15 | View → |
| 4 | Insider transaction | 2025-07-15 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $1.05
- Market Cap
- $131.35 million
- 52-Week Range
- $1.00 – $3.06
- Average Volume
- 1.49 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.